Novel injectable gel (system) as a vehicle for human articular chondrocytes in cartilage tissue regeneration

Journal of Tissue Engineering and Regenerative Medicine

Volumn 3, Issue 2, 2009, Pages 97-106

  Pereira, R C ^a,c   Scaranari, M ^a   Castagnola, P ^b   Grandizio, M ^d   Azevedo, H S ^c   Reis, R L ^c   Cancedda, R ^a,b   Gentili, C ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF MINHO   (Portugal)

^d Ospedale S Antonio Recco   (Italy)

Author keywords

Animal model; Biomaterial; Cartilage tissue engineering; Cell culture; Extracellular matrix (ECM)

Indexed keywords

BIOMATERIALS; BODY FLUIDS; CARTILAGE; CELL ENGINEERING; CELLS; HYDROGELS; MAMMALS; TISSUE REGENERATION;

ANIMAL MODEL; CARRAGEENANS; CARTILAGE TISSUE ENGINEERING; CARTILAGE TISSUES; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX; GEL SYSTEMS; HUMAN ARTICULAR CHONDROCYTES; INJECTABLE GEL; INJECTABLES;

CELL CULTURE;

CARRAGEENAN; FIBRIN; HYALURONIC ACID; PRIMER DNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BIODEGRADABILITY; CARTILAGE CELL; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; COW; ENCAPSULATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROGEL; IMPLANT; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE REGENERATION; ANIMAL; ANIMAL MODEL; CATTLE; CELL CULTURE; CYTOLOGY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANIMALS; BASE SEQUENCE; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; CHONDROCYTES; DNA PRIMERS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; HYDROGELS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MIDDLE AGED; MODELS, ANIMAL; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

EID: 66949129792     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.145     Document Type: Article

References (38)

1. Ando W, Tateishi K, Hart DA, et al. 2007; Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials 28(36): 5462-5470.
2. Banfi A, Muraglia A, Dozin B, et al. 2000; Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28(6): 707-715.
3. Bartkowiak A, Hunkeler D. 2001; Carrageenan-oligochitosan microcapsules: optimization of the formation process (1). Colloids Surf B Biointerfaces 21(4): 285-298.
4. Brittberg M, Lindahl A, Nilsson A, et al. 1994; Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331(14): 889-895.
5. Cancedda R, Dozin B, Giannoni P, et al. 2003; Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 22(1): 81-91.
6. Chung C, Burdick JA. 2008; Engineering cartilage tissue. Adv Drug Deliv Rev 60(2): 243-262.
7. DeFail AJ, Chu CR, Izzo N, et al. 2006; Controlled release of bioactive TGFβ1 from microspheres embedded within biodegradable hydrogels. Biomaterials 27(8): 1579-1585.
8. Denizot F, Lang R. 1986; Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89(2): 271-277.
9. Dozin B, Malpeli M, Camardella L, et al. 2002; Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol 21(5): 449-459.
10. Endres M, Neumann K, Schroder SE, et al. 2007; Human polymer-based cartilage grafts for the regeneration of articular cartilage defects. Tissue Cell 39(5): 293-301.
11. Eyrich D, Brandl F, Appel B, et al. 2007a; Long-term stable fibrin gels for cartilage engineering. Biomaterials 28(1): 55-65.
12. Eyrich D, Wiese H, Maier G, et al. 2007b; In vitro and in vivo cartilage engineering using a combination of chondrocyte-seeded long-term stable fibrin gels and polycaprolactone-based polyurethane scaffolds. Tissue Eng 13(9): 2207-2218.
13. Frey MR, , Dise RS, Edelblum KL, et al. 2006; p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration. EMBO J 25(24): 5683-5692.
14. Gelse K, Schneider H. 2006; Ex vivo gene therapy approaches to cartilage repair. Adv Drug Deliv Rev 58(2): 259-284.
15. Giannoni P, Cancedda R. 2006; Articular chondrocyte culturing for cell-based cartilage repair: needs and perspectives. Cells Tissues Organs 184(1): 1-15.
16. Gutowska A, Jeong B, Jasionowski M, et al. 2001; Injectable gels for tissue engineering. Anat Rec 263(4): 342-349.
17. Hunziker EB. 1999; Biologic repair of articular cartilage. Defect models in experimental animals and matrix requirements. Clin Orthop Relat Res 367: (suppl): S135-146.
18. Hunziker EB. 2000; Articular cartilage repair: problems and perspectives. Biorheology 37(1-2): 163-164.
19. Johnstone B, Hering TM, Caplan AI, et al. 1998; In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238(1): 265-272.
20. Kim J, Kim IS, Cho TH, et al. 2007; Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 28(10): 1830-1837.
21. Lee KY, Mooney DJ. 2001; Hydrogels for tissue engineering. Chem Rev 101(7): 1869-1879.
22. Liao YH, Jones SA, Forbes B, et al. 2005; Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv 12(6): 327-342.
23. Liu W, Cao Y. 2007; Application of scaffold materials in tissue reconstruction in immunocompetent mammals: our experience and future requirements. Biomaterials 28(34): 5078-5086.
24. Malpeli M, Randazzo N, et al. 2004; Serum-free growth medium sustains commitment of human articular chondrocyte through maintenance of Sox9 expression. Tissue Eng 10(1-2): 145-155.
25. McHale MK, Setton SA, Chilkoti A, et al. 2005; Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng 11(11-12): 1768-1779.
26. Mueller-Rath R, Gavenis K, Gravius S, et al. 2007; In vivo cultivation of human articular chondrocytes in a nude mouse-based contained defect organ culture model. Biomed Mater Eng 17(6): 357-366.
27. Neuss S, Apel C, Buttler P, et al. 2008; Assessment of stem cell/biomaterial combinations for stem cell-based tissue engineering. Biomaterials 29(3): 302-313.
28. Osakada F, Ikeda H, Mandai M, et al. 2008; Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 26(2): 215-224.
29. Park H, Temenoff JS, Holland TA, et al. 2005; Delivery of TGF-β1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 26(34): 7095-7103.
30. Park H, Temenoff JS, Tabata Y, et al. 2007; Injectable biodegradable hydrogel composites for rabbitmarrowmesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 28(21): 3217-3227.
31. Peterson L, Minas T, Brittberg M, et al. 2000; Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res 374: 212-234.
32. Piyakulawat P, Praphairaksit N, Chantarasiri N, et al. 2007; Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac. AAPS PharmSciTech 8(4): E97.
33. Schuller GC, Tichy B, Majdisova Z, et al. 2008; An in vivo mouse model for human cartilage regeneration. J Tissue Eng Regen Med 2(4): 202-209.
34. Temenoff JS, Mikos AG. 2000a; Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 21(23): 2405-2412.
35. Temenoff JS, Mikos AG. 2000b; Review: tissue engineering for regeneration of articular cartilage. Biomaterials 21(5): 431-440.
36. Thommes M, Kleinebudde P. 2008; The behavior of different carrageenans in pelletization by extrusion/spheronization. Pharm Dev Technol 13(1): 27-35.
37. Tuli R, Li W, Tuan RS, et al. 2003; Current state of cartilage tissue engineering. Arthritis Res Ther 5(5): 235-238.
38. Ulivi V, Tutolo G, Mallein-Gerin F, et al. 2006; A common pathway in differentiation and inflammation: p38 mediates expression of the acute phase SIP24 iron binding lipocalin in chondrocytes. J Cell Physiol 206(3): 728-737.